Appropriate Used of Oral & Injectable Hypoglycemic Drugs for Type-2 Diabetic Patients among Two ethnic Groups: Muslims And other Than Muslims Residing in Karachi.  

Authors: Rameez Ur Rehman, Kamal Haider, Imranullah Sharif

1 Hamdard University, Karachi,
2 Federal Urdu University Of Arts, Science &Technology Karachi,
3 Hamdard University, Karachi, Pakistan
4 Pakistan Institute Of Quality, Karachi, Pakistan

Volume 22 | Issue 3

Published: October 23, 2026

Abstract

Type-2 diabetes patient age group influenced by adverse events, therapeutic outcome, responsible for increased morbidity and mortality rates as well treatment cost. Study design : A Longitudinal-comparative used. Methods: The study was a multi-centred. The tolerability of hypoglycemic drugs and adherence among both age groups analyzed through a structured questionnaire. Data collected from January - 15th of June 2015. The SPSS 22nd version used for data entry & analysis, & Chi-Square test applied to see the significance .Results: Study found that adult old age group was much affected by using insulin and observed significant difference in adverse event (p<0.001) & (p=0.05). We report microvascular event (p=0.05) and macrovascular disease complication (p=0.001) were more against younger adult Type-2 patients, while using oral or/and injectable (insulin) hypoglycemic drugs. Whereas among young adult with Type-2 diabetes patients reinforce the used of insulin with feasibility and shows the least glycemic effect towards microvascular events. In female Type-2 diabetes patients, we observed significance in the rate of adverse events along with microvascular disease and associated with extensive morbidity as compared to male patients (p<0.001) & (p=0.05). Conclusion: In Karachi, we found that Insulin therapy was much safer in young adults with Type-2 diabetes as it’s accompanied by education and training, compared to adult old with Type-2 diabetes. Whereas adults old with Type-2 diabetes were found more comfort and feasible while using oral hypoglycemic agents.

Keywords: Type-2, Hypoglycemic Drugs, Chi-Square Test, Glycemic control, Hypoglycemic, Microvascular.

DOI: (All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.)